Penny stock picks | research with support and resistance for trading | stock investing
day investing picks penny stock trading
Skip Navigation Links
    Home
    •   About US
    Market Activity
    World Indices
    Market Watch
    Customer Service
    Learning Center
    Economic Event
    Login


Join Now
Advertise 2 my advertising 3 of 5
 

NEKTAR THERAPEUTICS COM support, resistance research

Stock : NKTR |   Stock Recommendations : Buy
Sector : Medical Equipment & Supplies |   First resistance : 7.26
Stock Name : NEKTAR THERAPEUTICS COM |   Second resistance : 13.15
Buy Near : 5.53 |   Third resistance : 17.00
StopLoss : 3.64 |   First Support : 3.64
Posted date : 11/2/2008 12:00:00 AM |   Second Support : 2.91


Nektar Therapeutics com (NKTR) given a nice double top breakout on 10/31/08 with good volume. Again many technical indicators also have given a buy signal, with

   rising moving average weekly and daily Stockhastic given a buy signal and ADX also given a buy signal. Nektar Therapeutics com (NKTR) reported positive Phase 1 data for its lead proprietary oncology product candidate, NKTR-102. As per technical indicator analysis this Stock looks good candidate for portfolio investment and also for day trading, Stock investing, trend trading | swing trading. Due to Stock market and economic condition keep tight stop loss on all position. Buy with our first target $7.26 and keep stop loss $3.64



Penny Stocks


Recent News Head Lines
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR
(Thu, 16 Jan 2020 18:37:52 +0000)
Pomerantz LLP is investigating claims on behalf of investors of Nektar Therapeutics (“Nektar” or the “Company”) (NASDAQ: NKTR). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. The investigation concerns whether Nektar and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
How An FDA Committee Pulled The Rug Out From This Highflying Biotech
(Wed, 15 Jan 2020 21:08:52 +0000)
Nektar Therapeutics pulled its application for a pain drug called oxycodegol after a Food and Drug Administration committee rejected it — sending NKTR stock into a slide Wednesday.
Nektar's Pain Drug Gets Adverse Advisory Committee Decision
(Wed, 15 Jan 2020 15:27:03 +0000)
Nektar (NKTR) to stop development of chronic pain candidate, NKTR-181, following two FDA advisory committees' decision to not recommend its approval.
Its opioid dissed by FDA advisors, S.F. drugmaker abandons program
(Wed, 15 Jan 2020 15:23:20 +0000)
A rejection of its experimental pain drug Tuesday forced Nektar Therapeutics Inc. to dump the program. In a rare indisputable rejection, two Food and Drug Administration advisory committees voted 27-0 to recommend that the FDA not approve the San Francisco company's oxycodegol, a slow-acting opioid aimed at chronic lower back pain. The FDA isn't required to live by the advisory committees' recommendation, but six hours later Nektar (NASDAQ: NKTR) said it would withdraw its approval request and make no further investment into the oxycodegol program.
Benzinga Pro's Top 5 Stocks To Watch For Wed., Jan. 15, 2020: GS, RSX, NKTR, NVAX, ACB
(Wed, 15 Jan 2020 14:17:55 +0000)
Benzinga Pro's Stocks To Watch For Wednesday Goldman Sachs (GS) - Shares were down 1.6% following mixed Q4 results and sparse details about an overhang which had been on investors' mind's, charges related ...


Never go against major trend for Penny stock trading | investing
  
Home for ۩ Day Trading | Breakout Stock trading system | Penny Stock Investing | Market Research
Contact Us | Affiliate | Disclaimer | Feedback | Help | Site Map | RSS  RSS
All Rights Reserved © 2000-2006 Flyingstock.com
Chart courtesy of StockCharts.com
Penny stock trading- NEKTAR THERAPEUTICS COM for penny stock investing Day Trading

This Service is solely an information service provided by the automated software tool & is for entertainment purposes only. It should be understood that there is no guarantee that past performance of our stock trading system or day trading Strategy or Penny stock picks will be indicative of future results.